O'Malley FP - Search Results

1

JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.

Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O'Malley FP, Egan SE, Andrulis IL. Reedijk M, et al. Breast Cancer Res Treat. 2008 Oct;111(3):439-48. doi: 10.1007/s10549-007-9805-3. Epub 2007 Nov 8. Breast Cancer Res Treat. 2008. PMID: 17990101

2

Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.

Figueiredo JC, Ennis M, Knight JA, McLaughlin JR, Hood N, O'Malley F, Andrulis IL, Goodwin PJ. Figueiredo JC, et al. Breast Cancer Res Treat. 2007 Sep;105(1):69-80. doi: 10.1007/s10549-006-9433-3. Epub 2006 Nov 18. Breast Cancer Res Treat. 2007. PMID: 17115108

3

Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.

Mulligan AM, O'Malley FP, Ennis M, Fantus IG, Goodwin PJ. Mulligan AM, et al. Breast Cancer Res Treat. 2007 Nov;106(1):39-47. doi: 10.1007/s10549-006-9471-x. Epub 2007 Jan 13. Breast Cancer Res Treat. 2007. PMID: 17221153

4

High-level JAG1 mRNA and protein predict poor outcome in breast cancer.

Dickson BC, Mulligan AM, Zhang H, Lockwood G, O'Malley FP, Egan SE, Reedijk M. Dickson BC, et al. Mod Pathol. 2007 Jun;20(6):685-93. doi: 10.1038/modpathol.3800785. Mod Pathol. 2007. PMID: 17507991 Free article.

5

Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.

Bane AL, Pinnaduwage D, Colby S, Reedijk M, Egan SE, Bull SB, O'Malley FP, Andrulis IL. Bane AL, et al. Breast Cancer Res Treat. 2009 Sep;117(1):183-91. doi: 10.1007/s10549-008-0087-1. Epub 2008 Jun 18. Breast Cancer Res Treat. 2009. PMID: 18563556 Free PMC article.

6

Prognostic effect of basal-like breast cancers is time dependent: evidence from tissue microarray studies on a lymph node-negative cohort.

Mulligan AM, Pinnaduwage D, Bull SB, O'Malley FP, Andrulis IL. Mulligan AM, et al. Clin Cancer Res. 2008 Jul 1;14(13):4168-74. doi: 10.1158/1078-0432.CCR-07-4543. Clin Cancer Res. 2008. PMID: 18593996

7

EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.

Bane AL, Mulligan AM, Pinnaduwage D, O'Malley FP, Andrulis IL. Bane AL, et al. Breast Cancer Res Treat. 2011 Jun;127(3):831-9. doi: 10.1007/s10549-011-1380-y. Epub 2011 Feb 15. Breast Cancer Res Treat. 2011. PMID: 21327470

8

CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the breast cancer family registry.

Mulligan AM, Pinnaduwage D, Bane AL, Bull SB, O'Malley FP, Andrulis IL. Mulligan AM, et al. Cancer. 2011 Apr 1;117(7):1350-9. doi: 10.1002/cncr.25642. Epub 2010 Nov 2. Cancer. 2011. PMID: 21425134 Free PMC article.

9

Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry.

Mulligan AM, Raitman I, Feeley L, Pinnaduwage D, Nguyen LT, O'Malley FP, Ohashi PS, Andrulis IL. Mulligan AM, et al. Clin Cancer Res. 2013 Jan 15;19(2):336-46. doi: 10.1158/1078-0432.CCR-11-3314. Epub 2012 Dec 4. Clin Cancer Res. 2013. PMID: 23213058 Free PMC article.

10

Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer.

Forse CL, Yilmaz YE, Pinnaduwage D, O'Malley FP, Mulligan AM, Bull SB, Andrulis IL. Forse CL, et al. Breast Cancer Res Treat. 2013 Feb;137(3):709-19. doi: 10.1007/s10549-012-2392-y. Epub 2013 Jan 4. Breast Cancer Res Treat. 2013. PMID: 23288345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters